产品英文名称 | Vimentin Polyclonal Antibody |
免疫原 | 合成多肽:Vimentin,AA:371-420 |
宿主 | 兔 |
反应性 | 人, 大鼠, 小鼠 |
应用 | ELISA, WB |
实验建议 | 最佳的工作稀释比例需要客户摸索优化。建议的起始尝试的稀释比为:WB:1:500-1:2000,ELISA:1:10000-1:20000。 |
克隆性 | 多克隆 |
纯化工艺 | 使用表位特异性的免疫原,通过亲和层析,从兔抗血清中亲和纯化抗体。 |
产品形式 | 液体溶液 |
浓度 | 1 mg/ml |
分子量 | 55 KD |
储存缓冲液 | PBS缓冲液(pH 7.4),含有0.5%BSA(稳定剂),0.02%叠氮化钠(防腐剂)和50%甘油。 |
保存建议 | 自发货之日起,-20°C可稳定保存1年。为最大限度的避免损失,请在打开管盖之前融化抗体并离心。我们建议使用前分装以避免反复冻融。 |
运输条件 | 蓝冰运输 |
警告 | 本文列出的产品仅供研究使用,不适用于人类或临床诊断。我们产品所推荐应用,不是建议使用我们的产品去违反任何专利或许可证。对于使用本产品可能发生的专利侵权或其他违规行为,我们不承担任何责任。 |
背景 | VIM (vimentin) encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by VIM is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in VIM causes a dominant, pulverulent cataract. |
基因ID | 7431 |
别名 | Vimentin |
其它 | 该抗体可检测内源蛋白 |
蛋白质ID | P08670 |
Fig.1. Western Blot analysis of Hela cells using Vimentin 多克隆 Antibody diluted at 1:500. Secondary antibody (catalog#: A21020) was diluted at 1:20000.
Fig.2. Immunohistochemical analysis of paraffin-embedded human-breast-cancer, antibody was diluted at 1:200.
Fig.3. Immunohistochemical analysis of paraffin-embedded human-breast-cancer, antibody was diluted at 1:200.
Fig.4. Immunohistochemical analysis of paraffin-embedded human-tonsil, antibody was diluted at 1:200.
Fig.5. Immunohistochemical analysis of paraffin-embedded human-tonsil, antibody was diluted at 1:200.
微信公众号
评价
目前还没有评论